USA flag logo/image

An Official Website of the United States Government


Note: The awards database is continually being updated to reflect accurate data as agencies upload their award information

Download to spreadsheetPrint
Displaying 101 – 125 of 6427 Awards
Company: CYTEX THERAPEUTICS INC. Agency/Program/Year/Phase: HHS / STTR / 2013 / 2
Abstract: DESCRIPTION (provided by applicant): The overall goal of this study is to develop a tissue-engineered total joint replacement from an engineered biomaterial scaffold combined with adult bone marrow-derived mesenchymal stem cells (MSCs) for regeneration ofthe entire femoral… more
Company: CYTOGRAFT TISSUE ENGINEERING, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … would benefit from a less invasive procedure. Expanded use of TAVI devices will also have a positive economic impact on the healthcare system, with decreased O.R. times, shorter hospital stays, and reduced complication rates. We have developed a technology called '… more
Company: DEKK-TEC, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 2
Abstract: …, monitor pharmacodynamics and toxicities. 2) Monitor tumor responses to DM-CHOC-PEN per imaging/examinations using RECIST guidelines. 3) Electronically store/analyze clinical data for toxicity, responses and tumor-organrelationships. 4) Continue to bank tumor tissue from pre-… more
Company: Deployable Space Systems (DSS) Agency/Program/Year/Phase: DOD / SBIR / 2013 / 2
Abstract: ABSTRACT: Deployable Space Systems, Inc. (DSS), in partnership with Emcore Photovoltaics (EMCORE), proposes the development and TRL 5/6 validation of an adhesive-less photovoltaic panel assembly, termed"HSA"for High Survivability Array. Space solar array adhesives… more
Company: DMETRIX, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: DESCRIPTION (provided by applicant): The ability to accurately detect the developing lesions at early stage in dental practice and to quantify the lesions will provide dentists with the opportunity of initiating early prophylactic treatment; correct diagnosis of a fractured tooth in is earliest… more
Company: DYNAVAX TECHNOLOGIES CORPORATION Agency/Program/Year/Phase: HHS / STTR / 2013 / 1
Abstract: …, blocks the development of HF when given prophylactically. This project attempts to confirm and expand the preclinical feasibility data and potential for IRS954 to be a novel therapy for HF with the following Specific Aims: Aim 1: Evaluate the pharmacokinetics and tissue… more
Company: Ecovative Design LLC Agency/Program/Year/Phase: EPA / SBIR / 2013 / 1
Abstract: …, but all attempts have still fallen short of an ideal ‘bio-plastic’. §The proposed concept is to demonstrate an ideal bio-plastic by using mycelium as the polymer, resin, or structural matrix. Preliminary studies have shown basidiomycete stipe tissue offers… more
Company: Eltron Research & Development LLC Agency/Program/Year/Phase: DOD / SBIR / 2013 / 1
Abstract: …ic and highly refractory with a melting point of>1000 & #176;C which will improve the thermal resistance of mat materials to be able to withstand 650 & #176;F minimum for 20 minutes minimum. We"ve developed a series of methods to provide excellent adhesion of our… more
Company: ENSION, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … proposes development of an infection resistant surface designed to promote normal healing for application to the transcutaneous drivelines of ventricular assist devices. Theproposed surface will incorporate a three-pronged approach to infection resistance; a low adhesion… more
Company: PROSOLIA, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … that enable rapid measurements without significant compromise to the analytical data. Herein, we propose to develop arobust mass spectrometry (MS) based surface sampling device that enables direct analysis of a variety of materials including biological tissue and live… more
Company: Excellims Corporation Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: DESCRIPTION: The ultimate goal of the Phase I SBIR project is to establish the feasibility of using ion mobility spectrometry (IMS) or liquid chromatography-IMS (LC-IMS) as a fast, selective and sensitive method for rapid monitoring of bio manufacturing processes for on-line use to improve the… more
Company: Luna Innovations Incorporated Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: DESCRIPTION (provided by applicant): Adhesion formation after intra-abdominal surgery poses a significant health risk, cited as a leading cause of small bowel obstruction and female infertility. Methods to prevent these adhesions are currently limited to barrier films which are… more
Company: FBS, Inc. Agency/Program/Year/Phase: DOD / SBIR / 2013 / 2
Abstract: …cing conditions are encountered to perform de-icing of the wing leading edge. Ultrasonic de-icing is achieved by driving the actuators to create ultrasonic shear stresses at the substrate/ice interface such that the ultrasonic stresses are greater than the adhesion strength of… more
Company: FOCALCOOL, LLC Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … also enables destructive biochemical processes. While numerousadjunctive therapies for acute myocardial infarctions (AMI) have been studied, innovative combination therapies are needed. Both hypothermia and gradual reperfusion have shown benefit in terms of saving heart tissue… more
Company: Nano Terra, Inc Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: Not Available
Company: GENOMICS USA, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 2
Abstract: … prototype (microarrays, PCR reagents, Hybridization Reagents, Specialized Software) for subsequent Beta Testing. This kit will be prepared under manufacturing control (ISO 13845) similar to the HLA-Chip products from GenUSA which are currently being launched into tissue… more
Company: GLSYNTHESIS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: …mster flank, reduced the size of this organ but only on the ipsilateral side These results suggest that this drug is a soft antiandrogen , expected to be active topically inandrogen-dependent maladies of the skin and scalp, but to be hydrolyzed by plasma or tissue enzymes, thus… more
Company: ADVAITA CORPORATION Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … medicine and drug discovery. To realize the much-heralded promise of personalized medicine, it is necessary to (a) accurately recognize and distinguish disease subtypes, (b) apply these diagnostic signatures at the level of the individual patient (and tissue type) over… more
Company: GVD Corporation Agency/Program/Year/Phase: EPA / SBIR / 2013 / 2
Abstract: … Chemical Vapor Deposition (iCVD) process. In this solvent-free process, GVD creates the pure PTFE fluoropolymer from reactive precursor vapors and deposits the PTFE as a uniform coating at the same time. Using iCVD, GVD and optimize PTFE’s surface energy, adhesion, and… more
Company: HIGH THROUGHPUT GENOMICS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 2
Abstract: … in Phase I. This platform uses a nuclease protection assay combined with universal PCR to produce targeted sequencing libraries. The lysis-only protocol means there is no need to extract RNA or DNA or to reverse transcribe RNA. Consequently, sequencing from fixed tissue is… more
Company: CAPRICOR, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 2
Abstract: … cells (CDCs), grown from a donor unrelated to the recipient, using a proprietary process exclusively licensed to Capricor. Autologous CDCs have demonstrated their utility as a regenerative agent: able to reduce infarct size (a.k.a scar size), add viable tissue mass, and… more
Company: CELDARA MEDICAL, LLC Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … due to associated toxicities. We have focused on targeting Plasmalemmal Vesicle Associated Protein-1 (Plvap/PV1), an endothelial specific protein with roles in angiogenesis8-10 and diapedesis of leukocytes11. PV1 is expressed on a subset of endothelia in normal … more
Company: IMMUNOMEDICS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: …. However, prior to initiating clinical studies, Immunomedicswill need to have a required PK/acute toxicity study performed in a relevant animal species (monkeys), an immunohistology study following the Points to Consider, showing the reactivity of the TF10 bsMAb with tissues,… more
Company: ENANTIGEN THERAPEUTICS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … (HBV) covalently closed circular DNA (cccDNA) formation and/or maintenance. HBV cccDNA is essential to the virus life cycle and its elimination during chronic infection is considered critical to durable therapy. However, because of the limitations of current HBV tissue… more
Company: GLYCOMIRA, LLC Agency/Program/Year/Phase: HHS / SBIR / 2013 / 2
Abstract: DESCRIPTION (provided by applicant): Chronic gingival inflammation of the soft tissue surrounding the tooth afflicts over half of all American adults. In the most severely affected, progression of this inflammatory process to the deeper periodontal ligaments and alveolar bone… more
Displaying 101 – 125 of 6427 Awards
Narrow Your Search
By Agency
By Year
By Phase
By Program
By State
By Company Ownership
By Company

Search Options

There are several categories such as “By Agency”, “By Year”, “By State” etc. Select a checkbox within a category to refine your search results.

Each of your selections is listed in the “Narrow Search Filters” bar. You can uncheck these selections to remove them.

Search for Either Criteria

When you select multiple values within a category, the results will include values that match either of the selections. For example, selecting “2005” and “2007” in the “By Year” category will display results that include either 2005 OR 2007 in the results.

Narrowing the Search Results

You can refine your search results across categories. To narrow down your results, select multiple values across different categories. The results will only include values that match the selections across the categories. For example, selecting “2005” in the “By Year” category and “NASA” in the “By Agency” category will only display the results that contain both “2005” AND “NASA” in the results.